The Mechanisms of Neuroprotection by Topical Rho Kinase Inhibition in Experimental Mouse Glaucoma and Optic Neuropathy

Sarah E. Quillen, Elizabeth C. Kimball, Kelsey A. Ritter-Gordy, Liya Du, Zhuochen Yuan, Mary E. Pease, Salaheddine Madhoun, Thao D. Nguyen, Thomas V. Johnson, Harry A. Quigley, Ian F. Pitha · 2024

Read The Mechanisms of Neuroprotection by Topical Rho Kinase Inhibition in Experimental Mouse Glaucoma and Optic Neuropathy by Sarah E. Quillen, Elizabeth C. Kimball, Kelsey A. Ritter-Gordy, Liya Du, Zhuochen Yuan, Mary E. Pease, Salaheddine Madhoun, Thao D. Nguyen, Thomas V. Johnson, Harry A. Quigley, Ian F. Pitha (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11583991.txt.

Description

A peer-reviewed research article from Europe PMC (2024). PurposeThe purpose of this study was to delineate the neuroprotective mechanisms of topical 2% ripasudil (Rip), a Rho kinase (ROCK) inhibitor.MethodsIn 340 mice, scheduled 2% Rip or balanced salt solution (BSS) saline drops were intermittently, unilaterally delivered. Intracameral microbead glaucoma (GL) injection increased intraocular pressure (IOP) from 1 day to 6 weeks (6W), whereas other mice underwent optic nerve (ON) crush.

Catalog record

CREATORSarah E. Quillen, Elizabeth C. Kimball, Kelsey A. Ritter-Gordy, Liya Du, Zhuochen Yuan, Mary E. Pease, Salaheddine Madhoun, Thao D. Nguyen, Thomas V. Johnson, Harry A. Quigley, Ian F. Pitha
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE53 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11583991

Browse the full library · About the Tower of Babel